Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  05/26/2005
 
Trade Name:  Focalin XR Extended-Release Capsules
 
Generic Name or Proper Name (*):  dexmethylphenidate
 
Indications Studied:  Treatment of Attention-Deficit Hyperactivity Disorder in children 6 years of age and older
 
Label Changes Summary:  Should not be used in children under 6 years of age Effectiveness in patients age 6 years of age and older was established in clinical studies PK studies also conducted Long-term effects in children have not been established New dosage form
 
Product Labeling:  Labeling  Opens a new window
 
PREA(P):  P
 
Sponsor:  Novartis
 
NNPS:  FALSE'
 
Therapeutic Category:  CNS Stimulant
 
-
-